Entera Bio Ltd. financial data

Symbol
ENTX on Nasdaq
Location
Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem, Israel
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.07K % +30.2%
Debt-to-equity 13.5 % -16.5%
Return On Equity -71.9 % +32.9%
Return On Assets -63.4 % +31.3%
Operating Margin -8.73K % +6.18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.9M shares +24.5%
Common Stock, Shares, Outstanding 45.7M shares +25.1%
Entity Public Float 58.8M USD +184%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 47.1M shares +25.1%
Weighted Average Number of Shares Outstanding, Diluted 47.1M shares +25.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 124K USD +25.3%
Cost of Revenue 124K USD +37.8%
Research and Development Expense 5.49M USD +27.7%
General and Administrative Expense 5.34M USD +8.21%
Operating Income (Loss) -10.8M USD -17.5%
Nonoperating Income (Expense) 57K USD +72.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.02M USD -28.6%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -10.8M USD -17.5%
Earnings Per Share, Basic 0 USD/shares -3.85%
Earnings Per Share, Diluted 0 USD/shares -3.85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.57M USD +24%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 262K USD +194%
Assets, Current 17M USD +132%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 114K USD +75.4%
Operating Lease, Right-of-Use Asset 194K USD -38.6%
Assets 17.4M USD +125%
Accounts Payable, Current 216K USD +17.4%
Liabilities, Current 1.57M USD +41.4%
Operating Lease, Liability, Noncurrent 41K USD -72.1%
Liabilities 2.17M USD +68.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 41K USD 0%
Retained Earnings (Accumulated Deficit) -122M USD -9.66%
Stockholders' Equity Attributable to Parent 15.2M USD +136%
Liabilities and Equity 17.4M USD +125%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.4M USD +24.6%
Net Cash Provided by (Used in) Financing Activities 13.3M USD +44357%
Net Cash Provided by (Used in) Investing Activities -8K USD
Common Stock, Shares Authorized 140M shares 0%
Common Stock, Shares, Issued 45.7M shares +25.1%
Common Stock, Par or Stated Value Per Share 0 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 11.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.7M USD +139%
Deferred Tax Assets, Valuation Allowance 20.9M USD +7.2%
Deferred Tax Assets, Gross 20.9M USD +7.12%
Operating Lease, Liability 272K USD -30.3%
Depreciation 8K USD -38.5%
Payments to Acquire Property, Plant, and Equipment 8K USD
Lessee, Operating Lease, Liability, to be Paid 301K USD -33.7%
Operating Lease, Liability, Current 170K USD +4.94%
Lessee, Operating Lease, Liability, to be Paid, Year Two 101K USD -45.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 198K USD +7.61%
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29K USD -54.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2K USD -97.7%
Deferred Tax Assets, Operating Loss Carryforwards 19.2M USD +10.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 83K USD
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%